Downregulation of estrogen receptor β inhibits lung adenocarcinoma cell growth

  • Authors:
    • Wenjuan Chen
    • Bo Xin
    • Hailin Pang
    • Le Han
    • Weiwei Shen
    • Zheng Zhao
    • Lian Duan
    • Peipei Cao
    • Lili Liu
    • Helong Zhang
  • View Affiliations

  • Published online on: March 5, 2019     https://doi.org/10.3892/or.2019.7044
  • Pages: 2967-2974
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Estrogen receptor β (ERβ) is an important ER subtype in lung adenocarcinoma. However, the functions and mechanisms of ERβ have not been fully elucidated. The aim of the present study was to investigate the biological effects and relevant mechanisms of ERβ in lung adenocarcinoma. The protein expression of ERβ was found to be higher in lung adenocarcinoma tissues compared with that in adjacent non‑cancerous tissues (n=75, P<0.001). Of note, ERβ protein expression was significantly correlated with tumor size (P=0.018), lymph node metastasis (P=0.041), clinical stage (P=0.041) and differentiation (P<0.001). In addition, ERβ protein expression in A549 cells was found to be higher compared with that in human bronchial epithelial cells (HBEs). Furthermore, knockdown of ERβ expression inhibited colony formation and cell invasion in vitro, whereas the number of metastatic tumors in the lungs of mice was decreased in vivo. Western blot analysis demonstrated that the expression of phosphorylated extracellular signal‑regulated kinase (pERK), matrix metalloproteinase (MMP)‑2 and MMP‑9 was decreased by downregulation of ERβ. Therefore, ERβ may play an important role in lung adenocarcinoma progression via the MEK/ERK signaling axis, and it may represent a novel therapeutic target for lung adenocarcinoma in the future.
View Figures
View References

Related Articles

Journal Cover

May-2019
Volume 41 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen W, Xin B, Pang H, Han L, Shen W, Zhao Z, Duan L, Cao P, Liu L, Zhang H, Zhang H, et al: Downregulation of estrogen receptor β inhibits lung adenocarcinoma cell growth. Oncol Rep 41: 2967-2974, 2019
APA
Chen, W., Xin, B., Pang, H., Han, L., Shen, W., Zhao, Z. ... Zhang, H. (2019). Downregulation of estrogen receptor β inhibits lung adenocarcinoma cell growth. Oncology Reports, 41, 2967-2974. https://doi.org/10.3892/or.2019.7044
MLA
Chen, W., Xin, B., Pang, H., Han, L., Shen, W., Zhao, Z., Duan, L., Cao, P., Liu, L., Zhang, H."Downregulation of estrogen receptor β inhibits lung adenocarcinoma cell growth". Oncology Reports 41.5 (2019): 2967-2974.
Chicago
Chen, W., Xin, B., Pang, H., Han, L., Shen, W., Zhao, Z., Duan, L., Cao, P., Liu, L., Zhang, H."Downregulation of estrogen receptor β inhibits lung adenocarcinoma cell growth". Oncology Reports 41, no. 5 (2019): 2967-2974. https://doi.org/10.3892/or.2019.7044